CRHR1 and myeloid sarcoma: Collectively, these results demonstrate that the CRHR1-selective antagonist R121919 reverses the maladaptive effects of MS on behavior and BNST electrophysiology, indicating that BNST CRHR1 is a major mediator of the long-lasting effects of MS in adult mice.